Add BrightSurf on Google Email

The Lancet


The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe

A large population-based study of European adults with blood cancers found that regional differences in treatment and care quality contribute to varying survival rates. The study analyzed data from 30 cancer registries covering all patients diagnosed in 20 European countries between 1997 and 2008.

SourceThe Lancet·JournalThe Lancet Oncology·DateJul 13, 2014

The Lancet Neurology: Post-concussion 'return to play' decision for footballers should be made solely by doctors, says new editorial

The Lancet Neurology calls for sports authorities to consider long-term neurological problems caused by repeated concussions in footballers. Many sporting organisations have drawn up new protocols to protect athletes who sustain a head injury, but the decision on return-to-play should be made solely by healthcare professionals.

SourceThe Lancet·JournalThe Lancet Neurology·DateJul 13, 2014

The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions

A new study published in The Lancet compares two drugs used to prevent blood clot formation during emergency heart attack treatment. The results suggest that systematic use of heparin rather than bivalirudin after primary percutaneous coronary intervention (PPCI) could save health services substantial sums of money while potentially im...

SourceThe Lancet·JournalThe Lancet·DateJul 4, 2014

The Lancet: Largest study to date finds insulin pumps result in better blood sugar control than multiple daily injections in people with type 2 diabetes

The OpT2mise trial found that insulin pumps result in better blood sugar control than multiple daily injections in people with type 2 diabetes. The study showed that patients using the pumps achieved a significantly greater reduction in average blood sugar levels and spent less time in hyperglycaemia.

SourceThe Lancet·JournalThe Lancet·DateJul 2, 2014

The Lancet: Patient Protection and Affordable Care Act catalyses unprecedented collaboration between health care and public health

The Affordable Care Act can improve the US population's health by focusing on disease prevention, health promotion, and early detection. The Act promotes collaboration between healthcare and public health systems, leading to better quality services and greater integration of public health entities into healthcare.

SourceThe Lancet·JournalThe Lancet·DateJun 30, 2014

The Lancet: Midwifery matters 'more than ever'

A major new Series in The Lancet emphasizes the critical role of midwifery in saving millions of women and children worldwide. Effective midwifery can prevent up to three-quarters of stillbirths and maternal deaths, and even modest improvements in coverage could halve current rates by 2030.

SourceThe Lancet·JournalThe Lancet·DateJun 22, 2014

The Lancet Infectious Diseases: Oldest ever schistosomiasis egg found may be first proof of early human technology exacerbating disease burden

A 6200-year-old schistosomiasis parasite egg discovered in Syria's Tell Zeidan grave suggests ancient agricultural irrigation systems may have spread the disease. The find, dating back a thousand years earlier than previous discoveries, highlights how human technology can exacerbate disease burdens.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateJun 19, 2014

The Lancet Psychiatry: Mental health patients more than twice as likely to be victims of homicide than the general public

A national study reveals that mental health patients are two and a half times more likely to be victims of homicide than the general public. The study found that 6% of homicide victims had been under mental health care in the year preceding their death, with many cases involving substance misuse and a history of violence.

SourceThe Lancet·JournalThe Lancet Psychiatry·DateJun 17, 2014

The Lancet Diabetes & Endocrinology: Intensive insulin provides survival

A landmark study shows that intensive insulin treatment significantly improves survival in patients with type 2 diabetes who have had a heart attack. The trial, which followed patients for up to 20 years, found that those who received intensified insulin treatment survived an average of 2.3 years longer than those on standard treatment.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateMay 12, 2014